Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported fourth-quarter adjusted EPS of $12.07, up 2% year-over-year, beating the ...
Regeneron Pharmaceuticals today announced financial results for the fourth quarter and full year 2024 and provided a business ...
Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...
Report with the AI impact on market trends - The global biotech market size is estimated to grow by USD 805.6 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR ...
In New Jersey, consumers and grocery stores have reported 12-unit packs of eggs selling for between $4 and $7. As eggs become ...
We compare 20 features including rewards, fees, how you can operate the account and more to calculate a product score. Our tables are ranked by scores, so look at the top of them for the best banks ...
This table shows the full range and dimensions of adult mattresses available to buy in the UK. Mattress name Size in centimetres Size in feet and inches Small single mattress 75 x 190cm 2ft 6in x 6ft ...
LFS estimates have been weighted to 2022 mid-year population estimates for periods from January to March 2019; headline UK seasonally adjusted series before this have been modelled, but other series ...
With a market cap of $77.3 billion, Regeneron Pharmaceuticals, Inc. (REGN) is a leading biotechnology company dedicated to discovering, developing, and commercializing innovative treatments for a ...
Regeneron Pharmaceuticals Inc.'s executives and board members overstated its key eye treatment’s average selling price, prompting a Department of Justice enforcement action and exposing the drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results